Jinni Wang

机构：Sun Yat-sen University, Sun Yat-sen University Cancer Center

发表论文 24 篇 · 总被引 118 次 · h-index 6

代表论文

• Novel target and treatment agents for natural killer/T-cell lymphoma (2023 · Journal of Hematology & Oncology · 被引 25)
• Comparison of Chemotherapy Combined With Chidamide Versus Chemotherapy in the Frontline Treatment for Peripheral T-Cell Lymphoma (2022 · Frontiers in Immunology · 被引 25)
• Diagnostic performance and prognostic value of circulating tumor DNA methylation marker in extranodal natural killer/T cell lymphoma (2023 · Cell Reports Medicine · 被引 21)
• Efficacy and safety of anlotinib in metastatic adenoid cystic carcinoma: a retrospective study (2022 · Translational Cancer Research · 被引 9)
• Comparison of chidamide-contained treatment modalities versus chemotherapy in the second-line treatment for relapsed or refractory peripheral T-cell lymphoma (2021 · Leukemia Research · 被引 8)
• Combination of Mitoxantrone Hydrochloride Liposome with Tislelizumab in Patients with Relapsed or Refractory NK/T Cell Lymphoma: A Phase Ib/Ⅱ Clinical Trial (2023 · Blood · 被引 6)